Lost in the market’s sharp rotation out of tech stocks is a really bullish call on major banks

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

We’re encouraged by Abbott stock trading but discouraged by moves in Honeywell

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Jim Cramer’s advice on Abbott Labs stock after a nearly $500 million baby formula verdict

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

We’re making a flurry of moves: trimming 2 stocks and buying 2 others that have lagged

We’re making four trades Monday morning. Shortly after the opening bell, we will be selling 100…

An ugly earnings report from a competitor is good news for Abbott Labs

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

Here are 3 major reports that could drive the stock market in the week ahead

Wall Street finished higher for the holiday-shortened trading week, with tech stocks leading the way. The…

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

The 4 key things we’re watching in the stock market this holiday-shortened week

The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new data…

Here are 9 stocks that can benefit from Fed interest rate cuts

The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected consumer…

Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks

Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club…

Jim Cramer says Nike should watch its back with Hoka running shoes doing so well

CNBC’s Jim Cramer sees footwear company Deckers Outdoor as a disruptive industry player that even big…

Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

We’re encouraged by an activist’s willingness to buy an Abbott rival, look past baby formula suits

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Here are the portfolio’s top 5 performers in a record-setting week for stocks

The bulls got what they wanted this week: cooler inflation data and record highs. The Dow…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving…

Newseum Global